Etofenamatum

Etofenamate Greencango must not be swallowed. Patients suffering from asthma, hay fever, swelling of the nasal mucosa (so-called nasal polyps) or chronic obstructive pulmonary disease, or chronic respiratory infections (particularly those associated with hay fever-like symptoms), are at greater risk of asthma attacks (so-called analgesic intolerance/analgesic asthma), localised swelling of the skin or mucous membranes (so-called Quincke's oedema) or urticaria during treatment with Etofenamate Greencango than other patients. In such patients, Etofenamate Greencango may be used only with certain precautions and under direct medical supervision. The same applies to patients with allergies to other substances, e.g. those manifesting as skin reactions, pruritus or urticaria. There is a risk of photosensitivity reactions; therefore, direct sun exposure and the use of sunbeds should be avoided during treatment and for two weeks thereafter. The possibility of systemic adverse reactions following cutaneous application of etofenamate cannot be excluded. The risk of these adverse reactions depends, among other factors, on the surface area treated, the amount applied and the duration of exposure. For this reason, this medicinal product should be used with caution in patients with impaired renal or hepatic function and should not be used for prolonged periods or over large areas of skin. Precautions should be taken to prevent children from coming into contact with treated areas of skin. Serious skin adverse reactions: very rarely, serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported in association with the use of non-steroidal anti-inflammatory drugs (see section 4.8). The risk of such reactions appears to be highest at the start of treatment, with onset occurring in most cases within the first month of therapy. Etofenamate Greencango must be discontinued at the first appearance of skin rash, mucosal lesions or any other sign of hypersensitivity.